Transcriptional Reprogramming Using a New Dual NIS Agonist Enhances Radioiodide Uptake and Facilitates Greater Predictive Utility for Thyroid Cancer Recurrence
Research output: Contribution to journal › Abstract › peer-review
Fingerprint
Dive into the research topics of 'Transcriptional Reprogramming Using a New Dual NIS Agonist Enhances Radioiodide Uptake and Facilitates Greater Predictive Utility for Thyroid Cancer Recurrence'. Together they form a unique fingerprint.